Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue
Launched by SAKARYA UNIVERSITY · Mar 7, 2025
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
The study received ethical approval from the Clinical Research Committee of Sakarya University Faculty of Medicine (Approval number: E-16214662-050.01.04-85,162-217) and was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The study protocol was thoroughly explained to all participants, and written informed consent was obtained prior to their inclusion. Recruitment took place between March 2021 and June 2022, involving patients who attended the clinics of the Department of Periodontology, Sakarya University. These patients were either in the maint...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Partially or fully edentulous patients rehabilitated with single or multiple implant-supported prostheses
- • Dental implants with functional restorations in place for a minimum of one year, -at least one screw-type titanium implant (single or two-piece) diagnosed with peri-implant mucositis or peri-implantitis and requiring treatment (for diseased groups)
- • Non-smokers or former smokers (individuals who had quit smoking for at least five years prior to the study)
- Exclusion Criteria:
- • Systemic contraindications to dental or surgical treatments
- • Active periodontal disease
- • Pregnancy or lactation
- • Autoimmune or inflammatory diseases
- • Uncontrolled diabetes (HbA1c \> 7)
- • Ongoing corticosteroid therapy
- • Current smoking
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sakarya, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported